Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-16

Clinical Trial Update: Use of Novel Plasma and Urinary Biomarkers to Predict the Development of Hepatorenal Syndrome in Cirrhotic Patients

View source ↗

Summary

This clinical trial update indicates ongoing recruitment for a study evaluating novel plasma and urinary biomarkers to predict the development of hepatorenal sy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The University of Hong Kong | Conditions: Hepatorenal Syndrome | Status: RECRUITING